Improvement in the neural stem cell proliferation in rats treated with modified "Shengyu" decoction may contribute to the neurorestoration. (13th May 2015)

• Record Type: Journal Article
• Authors: Chen, Miao-Miao; Zhao, Guang-Wei; He, Peng; Jiang, Zheng-Lin; Xi, Xin; Xu, Shi-Hui; Ma, Dong-Ming; Wang, Yong; Li, Yong-Cai; Wang, Guo-Hua
• Is Part Of: Journal of ethnopharmacology. Volume 165(2015)
• Page Start: 9
• Page End: 19
• Publication Date: 2015-05-13
• Subjects: BrdU 5-Bromo-2׳-deoxy-uridine -- GDNF glial cell line-derived neurotrophic factor -- GFAP glial fibrillary acidic protein -- MSD modified "Shengyu" decoction -- NCAM neural cell adhesion molecule -- NeuN neuron-specific nuclear protein -- NGF nerve growth factor -- Nogo-A neurite outgrowth inhibitor-A -- NSC neural stem/progenitor cell -- TBI traumatic brain injury -- TN-C tenascin-C; Rat -- Traumatic brain injury -- Neurorestoration -- "Shengyu" decoction -- Medicinal herbs -- Traditional medicine; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2015.02.037
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: "Shengyu" decoction, a traditional Chinese medicine, has been used to treat diseases with deficit in "qi" and "blood". The modified "Shengyu" decoction (MSD) used in the present study was designed to treat traumatic brain injury (TBI) on the basis of the "Shengyu" decoction, in which additional four herbs were added. Many ingredients in these herbs have been demonstrated to be effective for the treatment of brain injury. The present study was performed to evaluate the neurorestorative effect and the underlying mechanisms of MSD on the rat brain after a TBI. Materials and methods: TBI was induced in the right cerebral cortex of adult rats using Feeney's weight-drop method. Intragastrical administration of MSD (1.0 ml/200 g) was begun 6 h after TBI. The neurological functions and neuronal loss in the cortex and hippocampus were determined. The levels of nerve growth-related factors GDNF, NGF, NCAM, TN-C, and Nogo-A and the number of GFAP + /GDNF +, BrdU + /nestin +, BrdU + /NeuN + immunoreactive cells in the brain ipsilateral to TBI were also measured. Moreover, the influences of MSD on these variables were observed at the same time. Results: We found that treatment with MSD in TBI rats ameliorated the neurological functions and alleviated neuronal loss. MSD treatment elevated the expression of GDNF, NGF, NCAM, and TN-C, and inhibited the expression of Nogo-A. Moreover, MSD treatment increased the number of GFAP + /GDNF +, BrdU + /nestin +, and BrdU + /NeuN + immunoreactive cells in the cortex and hippocampus. Conclusion: The present results suggest that MSD treatment in TBI rats could improve the proliferation of neural stem/progenitor cells and differentiation into neurons, which may facilitate neural regeneration and tissue repair and thus contribute to the recovery of neurological functions. These effects of modified "Shengyu" decoction may provide a foundation for the use of MSD as a prescription of medicinal herbs in the traditional medicine to treat brain injuries in order to improve the neurorestoration. Graphical abstract: